Covid-19 cases rise in India: Existing vaccines protect against JN.1 sub-variant? What expert says

Along with this, the threat of JN.1 sub-variant is also being seen; its cases are being reported in Kerala...

In an interaction with Livemint, Dr. Gurmeet Singh Chabbra, Director-Pulmonary, Marengo Asia Hospitals Faridabad said that according to CDC, vaccines will not block completely JN.1 infections, they should reduce likely hood of severe illness and hospitalisation. ..

Most vaccines available in INDIA were developed against the ancestral variant of SARs- cov-2 and have only been tested against initial Omicron variants and were found effective," he said..

As per WHO, Pirola and JN.1 were effectively neutralised by serum from humans who had had covid infection and received covid vaccination as well but not neutralized by serum of animals who only received vaccination and did not have natural covid infection..

As per WHO current available vaccines continue to protect against severe disease and death from JN.1 and other circulating variants of SARs- cov-2 he added...

You might be interested in